Polymerase assays for lead discovery: An overall review of methodologies and approaches.

Polymerases represent an attractive molecular target for antibacterial drug development, antiviral intervention and cancer therapy. Over the past decade, academic groups and scientists from pharmaceutical industry have developed a large plethora of different functional assays to monitor the enzymatic reaction catalyzed by polymerases. These assays were used to enable high-throughput screening (HTS) for lead discovery purposes, as well as hit-to-lead (H2L) drug profiling activities. In both cases the choice of the assay technology is critical and to the best of our knowledge, there is no review available to help scientists to choose the most suitable assay. This review summarizes the most common functional assays developed to monitor the enzymatic activity of polymerases and discusses the advantages and disadvantages of each assay. Assays are presented and evaluated in term of cost, ease of use, high-throughput screening compatibility and liability towards delivering false positives and false negatives.

[1]  D. Bojanic,et al.  Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.

[2]  R. Wood,et al.  DNA polymerases and cancer , 2011, Nature Reviews Cancer.

[3]  R. Koff.  Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection , 2014, Alimentary pharmacology & therapeutics.

[4]  K. Saxena,et al.  Biophysical investigation and conformational analysis of p38α kinase inhibitor doramapimod and its analogues , 2016 .

[5]  Charles A. Lesburg,et al.  Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site , 1999, Nature Structural Biology.

[6]  A. Shapiro,et al.  A homogeneous, high-throughput fluorescence resonance energy transfer-based DNA polymerase assay. , 2005, Analytical biochemistry.

[7]  P. Anderson,et al.  L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase , 1995, Antimicrobial agents and chemotherapy.

[8]  S. Sturla,et al.  Quantification of pyrophosphate as a universal approach to determine polymerase activity and assay polymerase inhibitors. , 2015, Analytical biochemistry.

[9]  Hongping Dong,et al.  Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling , 2016, PLoS pathogens.

[10]  M. Otto,et al.  Inhibition of Hepatitis C Replicon RNA Synthesis by β-D-2′-deoxy-2′-fluoro-2′-C-Methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication , 2006, Antiviral chemistry & chemotherapy.

[11]  A. Marx,et al.  A molecular beacon for quantitative monitoring of the DNA polymerase reaction in real-time. , 2002, Angewandte Chemie.

[12]  Eoin Coakley,et al.  Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. , 2014, The New England journal of medicine.

[13]  A. Marx,et al.  Small Molecule Inhibitors of Human DNA Polymerase λ. , 2011, ACS chemical biology.

[14]  David J. Marchant,et al.  Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus , 2018, Scientific Reports.

[15]  U. H. Danielson,et al.  Biophysics in drug discovery: impact, challenges and opportunities , 2016, Nature Reviews Drug Discovery.

[16]  Grace Campagnola,et al.  High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. , 2011, Antiviral research.

[17]  L. Bastide,et al.  Progress in targeting bacterial transcription. , 2007, Drug discovery today.

[18]  S. Nelson,et al.  A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum , 2014, Journal of biomolecular screening.

[19]  I. Chopra,et al.  Bacterial RNA polymerase: a promising target for the discovery of new antimicrobial agents. , 2007, Current opinion in investigational drugs.

[20]  Carolina Q. Sacramento,et al.  The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication , 2017, Scientific Reports.

[21]  David M. Jameson,et al.  [12] Fluorescence anisotropy applied to biomolecular interactions , 1995 .

[22]  D. Earnshaw,et al.  Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus , 1992, Antimicrobial Agents and Chemotherapy.

[23]  C. Kao,et al.  An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies , 2010 .

[24]  T. Steitz,et al.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. , 1992, Science.

[25]  D. Whitcombe,et al.  Detection of PCR products using self-probing amplicons and fluorescence , 1999, Nature Biotechnology.

[26]  D. Plant,et al.  High-Throughput Screening of RNA Polymerase Inhibitors Using a Fluorescent UTP Analog , 2006, Journal of biomolecular screening.

[27]  Sanjay Tyagi,et al.  Molecular Beacons: Probes that Fluoresce upon Hybridization , 1996, Nature Biotechnology.

[28]  Christopher P Austin,et al.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. , 2010, Journal of medicinal chemistry.

[29]  T. Steitz.  DNA Polymerases: Structural Diversity and Common Mechanisms* , 1999, The Journal of Biological Chemistry.

[30]  B. Shoichet.  Screening in a spirit haunted world. , 2006, Drug discovery today.

[31]  P. Niyomrattanakit,et al.  A Fluorescence-Based Alkaline Phosphatase–Coupled Polymerase Assay for Identification of Inhibitors of Dengue Virus RNA-Dependent RNA Polymerase , 2011, Journal of biomolecular screening.

[32]  L. Kiss,et al.  A fluorescence polarization based assay for the identification and characterization of polymerase inhibitors. , 2016, Bioorganic & medicinal chemistry letters.

[33]  D. Richman,et al.  Antiviral drug resistance. , 2006, Antiviral research.

[34]  K. Murakami,et al.  Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis , 2018, Molecular cell.

[35]  S. Hay,et al.  A quantitative fluorescence‐based steady‐state assay of DNA polymerase , 2014, The FEBS journal.

[36]  J. Falgueyret,et al.  A High-Throughput Continuous Assay for Screening and Characterization of Inhibitors of HIV Reverse-Transcriptase DNA Polymerase Activity , 2011, Journal of biomolecular screening.

[37]  Scott A. Busby,et al.  Identifying Initiation and Elongation Inhibitors of Dengue Virus RNA Polymerase in a High-Throughput Lead-Finding Campaign , 2015, Journal of biomolecular screening.

[38]  O. Peersen,et al.  A fluorescence polarization-based screening assay for nucleic acid polymerase elongation activity. , 2007, Analytical biochemistry.

[39]  G. Maga,et al.  Selective Interaction of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Nonnucleoside Inhibitor Efavirenz and Its Thio-Substituted Analog with Different Enzyme-Substrate Complexes , 2000, Antimicrobial Agents and Chemotherapy.

[40]  S. LaPlante,et al.  Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. , 2004, Bioorganic & medicinal chemistry letters.

[41]  A. C. Krueger,et al.  Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530). , 2018, Journal of medicinal chemistry.

[42]  R. Hartmann,et al.  A detective story in drug discovery: elucidation of a screening artifact reveals polymeric carboxylic acids as potent inhibitors of RNA polymerase. , 2013, Chemistry.

[43]  A. Jadhav,et al.  A Comprehensive Strategy to Discover Inhibitors of the Translesion Synthesis DNA Polymerase κ , 2012, PloS one.

[44]  Arkady Mustaev,et al.  Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase , 2001, Cell.

[45]  Björn Sjögreen,et al.  The real-time polymerase chain reaction. , 2006, Molecular aspects of medicine.

[46]  U. Haupts,et al.  Homogeneous fluorescence readouts for miniaturized high-throughput screening: theory and practice. , 1999, Drug discovery today.

[47]  A. Berdis.  DNA polymerases as therapeutic targets. , 2008, Biochemistry.

[48]  B. Malcolm,et al.  A continuous nonradioactive assay for RNA-dependent RNA polymerase activity. , 2004, Analytical biochemistry.

[49]  D. Ullmann,et al.  PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B. , 2017, MedChemComm.

[50]  D. Earnshaw,et al.  FlashPlate Scintillation Proximity Assays for Characterization and Screening of DNA Polymerase, Primase, and Helicase Activities , 2001, Journal of biomolecular screening.

[51]  S. V. Van Doren,et al.  Rapid determination of enzyme kinetics from fluorescence: overcoming the inner filter effect. , 2007, Analytical biochemistry.

[52]  D. Hazuda,et al.  HIV-1 antiretroviral drug therapy. , 2012, Cold Spring Harbor perspectives in medicine.

[53]  E S Bishop,et al.  Characterization of PicoGreen interaction with dsDNA and the origin of its fluorescence enhancement upon binding. , 2010, Biophysical journal.

[54]  M. Mcgrath,et al.  Structural basis for RNA replication by the hepatitis C virus polymerase , 2015, Science.

[55]  J. Owicki,et al.  Fluorescence Polarization and Anisotropy in High Throughput Screening: Perspectives and Primer , 2000, Journal of biomolecular screening.

[56]  P. Lewis,et al.  Bacterial Transcription as a Target for Antibacterial Drug Development , 2016, Microbiology and Molecular Reviews.

[57]  P. White,et al.  A Fluorescence-Based High-Throughput Screen to Identify Small Compound Inhibitors of the Genotype 3a Hepatitis C Virus RNA Polymerase , 2013, Journal of biomolecular screening.

[58]  A. Palani,et al.  Development of a New Structural Class of Broadly Acting HCV Non‐Nucleoside Inhibitors Leading to the Discovery of MK‐8876 , 2017, ChemMedChem.